🔍 Observations
Topline
- Net sales surged 27.1% YoY (₹131,458M → ₹167,114M), driven by broad-based geographic expansion and the Ichnos Sciences consolidation effect post-demerger.
- Q4FY26 net sales of ₹37,603M grew 16.8% YoY vs Q4FY25’s ₹32,201M, though sequentially softer vs Q3FY26’s ₹38,880M — slight volume moderation at year-end.
- Other operating income jumped to ₹2,711M in FY26 vs ₹1,759M in FY25, reflecting licensing/milestone receipts boosting reported revenue quality.
Bottomline
- Reported PAT: ₹13,620M in FY26 vs ₹10,471M in FY25 (+30.1% YoY), but exceptional losses of ₹22,661M (vs ₹3,728M prior year) dominate the narrative — pre-exceptional PBT was ₹42,508M vs ₹17,720M (+139.9% YoY), a far stronger underlying picture.
- Q4FY26 PAT of ₹3,013M was inflated by negative current tax (refund of ₹301M) — normalized earnings were lower; Q3FY26 PAT of ₹4,032M was cleaner.
- Basic EPS: ₹48.26 in FY26 vs ₹37.11 in FY25 — EPS growth understates operational improvement given the drag from escalating exceptional charges.
Margins
- EBITDA proxy (pre-exceptional PBT + Finance costs + D&A): ₹42,508M + ₹2,087M + ₹5,735M = ₹50,330M on revenue of ₹169,825M → EBITDA margin ~29.6% in FY26 vs (₹17,720M + ₹2,071M + ₹4,860M) = ₹24,651M on ₹133,217M → 18.5% in FY25. A 1,110 bps margin expansion.
- Reported net margin: ₹13,620M / ₹169,825M = 8.0% — depressed by exceptional items; pre-exceptional PBT margin = 25.0%.
- Cost of materials + stock-in-trade consumed ₹47,475M (net of inventory changes ₹6,106M) = ₹41,369M effective material cost on ₹167,114M net sales = 24.8% — improved from prior year’s effective ~32.7%.
Growth Trajectory
- Revenue CAGR implied (FY25→FY26): +27.1% — sustainable pace uncertain; Ichnos consolidation is a one-time step-up in the base.
- Employee costs grew 18.4% YoY (₹30,221M → ₹35,779M) — below revenue growth, indicating early operating leverage.
- Other expenses grew 13.6% YoY (₹35,950M → ₹40,848M) — again below revenue growth, reinforcing operating leverage thesis.
🧮 Profit & Loss Statement
🧮 Balance Sheet
🧮 Cash Flows Statement
🟢 Green Flags
- Pre-exceptional EBITDA margin expanded ~1,110 bps YoY to ~29.6% — structural profitability improvement, not a one-quarter anomaly.
- OCF turned sharply positive: ₹34,450M in FY26 vs negative ₹8,276M in FY25 — business now self-funding after two years of cash burn.
- All debt erased: Borrowings (current + non-current) went from ₹21,942M to nil — balance sheet deleveraged completely, removing refinancing risk.
- Pre-exceptional PBT grew 139.9% YoY (₹17,720M → ₹42,508M) — earnings power has more than doubled on the same asset base.
- Employee and other expenses grew sub-revenue, delivering operating leverage — a positive inflection for margin sustainability.
- Inventory build (₹30,285M → ₹34,308M) is modest relative to revenue growth, suggesting demand pull rather than supply push.
- EPS grew 30% YoY even after absorbing ₹22,661M in exceptional charges — underlying EPS accretion is substantially higher.
🔴 Red Flags
- Trade receivables ballooned 48.5% YoY (₹33,419M → ₹49,634M) on 27.1% revenue growth — DSO deterioration signals either aggressive revenue recognition or collections stress in key geographies.
- Exceptional losses of ₹22,661M in FY26 (vs ₹3,728M in FY25) are accelerating — six-fold increase with limited transparency in disclosed line items; recurring “exceptional” charges question the label.
- Other non-current liabilities surged from nil to ₹15,361M — a large, unexplained liability build that warrants scrutiny (likely Ichnos/demerger-related contingencies).
- Other financial liabilities (non-current) doubled: ₹4,760M → ₹8,194M — further liability accretion outside formal borrowings.
- Capex: ₹13,577M in FY26 vs ₹7,507M in FY25 — an 80.9% jump; FCF = OCF ₹34,450M minus capex ₹13,577M = ₹20,873M. Positive but capex trajectory needs monitoring.
- Cash declined: ₹16,757M → ₹11,747M despite positive OCF — financing outflows (debt repayment ₹22,457M + dividend ₹1,410M) consumed the operating surplus.
- Intangible assets jumped from ₹10,972M to ₹19,421M (+77%) — heavy intangible accumulation raises amortization drag risk and asset quality questions.
📊 Balance Sheet Analysis
- Debt-free exit: Complete repayment of ₹21,942M in borrowings is the single biggest balance sheet improvement; net worth grew from ₹88,494M to ₹105,121M (+18.8%).
- Asset quality concern: Trade receivables at ₹49,634M vs total current liabilities of ₹63,764M — receivables represent 77.8% of current liabilities; elevated collection risk.
- Deferred tax assets of ₹12,466M signal significant carried-forward losses/timing differences — large DTA balances typically indicate prior-year losses that must be worked off against future profits.
- Working capital has expanded materially: Inventory + receivables = ₹83,941M vs prior year ₹63,705M (+31.7%) — growth is working capital intensive and will constrain FCF if receivables don’t normalize.
💰 Cash Flow Analysis
- OCF swing from -₹8,276M to +₹34,450M is the headline — driven by trade payable increase of ~₹7,000M and operating profit expansion, partially offset by ₹17,505M receivable build.
- Capex of ₹13,577M vs D&A of ₹5,735M — capex/D&A ratio of 2.4x signals aggressive investment phase; asset base is being built out significantly.
- Financing outflows of ₹27,087M (net debt repayment + interest + dividends) fully absorbed OCF surplus — net cash position declined by ₹5,010M despite a profitable year.
- FCF (OCF – Capex) = ₹34,450M – ₹13,577M = ₹20,873M — first year of meaningful positive FCF generation, a significant milestone for the company’s capital cycle.
💡 Investment Outlook
Glenmark has crossed a critical inflection: pre-exceptional profitability doubled, the balance sheet is debt-free, and OCF turned robustly positive — three conditions rarely achieved simultaneously.
The primary overhang is the receivables explosion (+48.5% YoY) and accelerating exceptional charges (₹22,661M), which cloud earnings quality and raise questions about the sustainability of reported profits.
If receivables normalize in H1FY27 and exceptional charges stabilize, the underlying FCF profile (~₹20,873M in FY26) supports a meaningful re-rating.
Investors should track DSO trends, exceptional item disclosures, and the ₹15,361M non-current liability build before assigning full credit to the operational turnaround.
Disclaimer: This post features ChartAlert-AI-generated financial content which may contain inaccuracies or errors. This commentary is strictly for informational purposes and does not constitute a recommendation to buy or sell any security. Investors are responsible for performing their own due diligence; always consult with a licensed financial advisor before making investment decisions.
Beyond the Price Action: Fundamental Analysis is Coming to ChartAlert
ChartAlert is evolving into integrated research with a future update that will embed fundamental data into your workflow. Alongside technical analysis, the new release will allow access to financial data, quarterly results review, earnings call transcripts, and valuation tools, connecting price action with corporate performance for smarter, data‑driven decisions.